TCM
MRTX

Tygh Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Tygh Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,369
Closed -$3.61M – 105
2021
Q2 		$3.61M Sell
22,369
-236
-1% -$38.1K 0.49% 75
2021
Q1 		$3.87M Buy
22,605
+878
+4% +$150K 0.55% 73
2020
Q4 		$4.77M Sell
21,727
-150
-0.7% -$32.9K 0.74% 64
2020
Q3 		$3.63M Buy
+21,877
New +$3.63M 0.69% 62